Last Thursday, the Trump administration released a proposed rule prohibiting hospitals that receive Medicare or Medicaid ...

At one particularly memorable session, a few actors used their brief moments offstage near the end of the final act — still ...

Below, STAT previews the three key questions that could define a potentially busy year in the worlds of substance use and ...

Several pharmaceutical companies that struck drug pricing deals with the White House said they're exempt from the Medicare ...

A proposal to deregulate AI products used in health care would shift the burden of vetting those tools onto health systems.

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Since his first term, Trump has promised to lower U.S. drug prices to levels charged in other rich countries. On Friday, the ...

The health sector is working to navigate what could be the most significant changes to the U.S. vaccine program in decades.

Under a rule proposed by the Trump administration, pharma companies and pharmacy benefit managers will still not have to post ...

Read the conversation that Nalis had with Morgentaler to learn how testosterone originally fell out of favor in medicine, how it came back, and what a castrated lizard had to do with it all. FDA ...

Good morning, Pharmalittle readers. This is Allison DeAngelis, filling in for Mr. Pharmalot. Today’s newsletter is brought to you by the dark roast Keurig pods I brought with me on my holiday travels.

Federal agencies that used to set up guardrails for health technology have transformed into cheerleaders for new risky technologies like AI.